Rockville, Nov. 15, 2022 (GLOBE NEWSWIRE) -- According to Fact.MR, the size of the global assisted reproductive technology market, projected to be US$ 24.91 billion in 2022, is anticipated to grow at a CAGR of 6% during the forecast period. By 2032, it is predicted that the assisted reproductive technology market is expected to be worth US$ 44.61 billion.
As society accepts assisted reproductive technology more frequently as a result of the adoption of more advanced technologies, such as time-lapse embryo imaging, pre-implantation genetic testing, magnetically activated cell sorting, and endometrial receptivity analysis testing, it is anticipated that the demand for assisted reproductive technology treatments may rise.
Want A Detailed Understanding of Market Functioning? Request for a Sample Here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4393
After the pandemic, telemedicine use in the assisted reproductive technology sector and technological advancement are expected to drive market growth. The use of telehealth in assisted reproductive technology therapies is still in its infancy. Due to advantages like continuous administration and remote monitoring, it has enormous future potential.
The main driver behind the adoption of assisted reproductive technology is the prevalence of infertility brought on by stressful lifestyles and other conditions. As a result of the rise in infertility, it is anticipated that the market for assisted reproductive technologies to expand over time. The aforementioned factors likely result in increased demand for assisted reproductive technology in the future.
The assisted reproductive technology market is expected to grow significantly as a result of various factors, including the growing number of single-parent families, greater acceptance of same-sex relationships, and others. Combining assisted reproductive technology and ovulation induction may result in noticeably higher multifetal pregnancies. It is essential to achieve a singleton gestation because multifetal pregnancy and the consequences that go along with it pose a significant risk to assisted reproductive technology along with ovulation induction.
Key Takeaways
- Based on type, the assisted reproductive technology market's IVF segment had the highest market share of 93%.
- The end-user segment for fertility clinics and other facilities, which accounted for the largest share of 80% of the total revenue, dominated the assisted reproductive technology market.
- With a 38% revenue share, Europe controlled the assisted reproductive technology market.
- A market share of 20% for assisted reproductive technology is expected to be accounted for by the end-use segment for hospitals and other settings.
- A healthy CAGR and a market share of 7% for assisted reproductive technology are predicted for the artificial insemination market segment.
- It is anticipated that North America to grow significantly. The increase, which is to produce a CAGR of 4.8% between 2022 and 2032, can be attributed to the excellent results that patients receiving treatment have reported.
Get Customization on this Report for Specific Country
https://www.factmr.com/connectus/sample?flag=RC&rep_id=4393
Competitive Landscape
Major corporations are putting in place a range of strategies, including new launches, R&D spending, and product portfolio expansion, to increase their assisted reproductive technology market share.
- With the launch of HavenCryo in June 2022, Inception Fertility broadened its ecosystem. HavenCryo is a long-term storage solution for reproductive tissue and cryopreservation that offers fertility specialists and patients a unique experience. There are tools for assisted reproduction in it (ART).
- In March 2022, CK Birla Healthcare opened Birla Fertility in New Delhi, its top assisted reproductive technology clinic.
- In January 2021, CooperSurgical bought Embryo Options, a renowned supplier of cryo-storage software for fertility clinics. By giving them access to its online resources, which will inform them about specimens stored for upcoming ART treatment cycles, the Embryo Options platform will benefit patients.
- In December 2021, CooperCompanies successfully acquired Generate Life Sciences. The top supplier of donor sperm and eggs for infertility treatments worldwide is Generate Life Sciences. It is anticipated that the 1.6 billion USD deal will benefit CooperCompanies' fertility services.
Key Segments in Assisted Reproductive Technology Industry Research
- By Procedure :
- Frozen Donor
- Frozen Non-donor
- Fresh Donor
- Fresh Non-donor
- Embryo Banking
- By Technology :
- In-vitro Fertilization
- Intracytoplasmic Sperm Injection (ICSI)
- Preimplantation Genetic Diagnosis (PGD)
- Surrogacy
- Artificial Insemination
- Intrauterine Insemination (IUI)
- Intracervical Insemination (ICI)
- Others
- Others
- In-vitro Fertilization
- By End User :
- Fertility Clinics
- Hospitals
- Others
- By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Explore Our Safe & Secure Payment Options for Quick Buy- https://www.factmr.com/checkout/4393
Table of Content
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Assisted Reproductive Technology Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.5. Global Assisted Reproductive Technology Market Analysis and Forecasts, 2022–2032
4.6. Assisted Reproductive Technology Market - Global Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Market Outlook
4.9. Assisted Reproductive Technology: Regional Funding Scenario
4.10. In Vitro Fertilization Costs, by Region, 2017
4.11. Assisted Reproductive Technology: Indication
Check out more related studies published by Fact.MR Research:
Preimplantation Genetic Testing Market- The preimplantation genetic testing market is projected to grow at nearly 9% CAGR and is likely to register an impressive valuation through 2032. The increasing prevalence of genetic disorders is broadening growth prospects.
Artificial Insemination Market - The global artificial insemination market is projected to rise rapidly at a CAGR of 7% from 2022 to 2026. At present, the market is valued at US$ 1.9 billion and is anticipated to reach US$ 2.5 billion by 2026-end.
Cataract Devices Market- The global cataract devices market stands at US$ 13.55 billion in 2022 and is forecasted to expand at a CAGR of 3.7% to reach a market size of US$ 19.49 billion by the end of 2032.
Veterinary Artificial Insemination Market- The veterinary artificial insemination market is forecast to garner a market value of US$ 3.16 Bn in 2022, anticipated to register a positive CAGR of 5.2% in the forecast period 2022-2032 and reach a value of US$ 5.24 Bn.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email: sales@factmr.com
